Branchoria Faster Reading Faster Reading

Read more fluently without falling for speed-reading hype.

Within Purpose

The leaflet sections you should not skim

Medicine leaflets can be skimmed for layout, but dosage, interactions, urgent side effects, and do-not-take warnings deserve close reading.

On this page

  • Headings that locate the safety critical parts
  • Dosage, timing, missed doses, and interactions
  • Warnings that change what you should do next
Preview for The leaflet sections you should not skim

Introduction

When the goal is increasing reading speed, medicine leaflets are one of the clearest examples of when not to read everything at the same pace. A patient information leaflet can often be skimmed for familiar background details, but sections covering dosage, timing, interactions, contraindications, and serious side effects deserve deliberate, careful reading. These leaflets exist because medicines can cause harm when taken incorrectly, combined with the wrong substances, or used by people with particular medical conditions. UK regulators require medicines to include patient information leaflets so patients can use medicines safely and effectively. [GOV.UK+2GOV.UK]GOV.UKmedicines packaging labelling and patient information leafletspackaging, labelling and patient information leaflets18 Dec 2014 — The MHRA approves all packaging and labelling information for medicine…

Medicine leaflets illustration 1 The fastest effective approach is selective reading: scan the leaflet structure first, then slow down dramatically when you reach instructions that affect what you take, when you take it, what you should avoid, and when you should seek medical help.

The leaflet sections you should not skim

Most medicine leaflets follow a similar structure. Once you recognise the layout, you can move quickly to the sections that carry the greatest safety value.

The sections that usually deserve close reading are:

  • Do not take this medicine if…
  • Warnings and precautions
  • Other medicines and interactions [GOV.UK]GOV.UKcommunications concerning medicines, medical…25 Mar 2025 — The MHRA continually monitors the safety of products, balancing their benef…
  • How to take the medicine
  • What to do if you miss a dose
  • Possible side effects requiring urgent action
  • Pregnancy, breastfeeding, driving, or alcohol warnings

These sections are specifically designed to prevent avoidable harm and medication errors. Regulatory guidance emphasises that patient information should help people make informed decisions about the safe and effective use of medicines. [GOV.UK]GOV.UKbest practice guidance on patient information leaflets29 Dec 2014 — This guidance sets out the legal framework for patient information leaflets as described in EU and national legislation and…

By contrast, if you have already used the medicine before, sections explaining the general purpose of the drug or administrative information about the manufacturer can often be reviewed more quickly.

Dosage, timing, missed doses, and interactions

Read dosage instructions word by word

Dosage instructions are not merely suggestions. Small details can change effectiveness or safety.

Pay particular attention to:

  • How much to take
  • How often to take it
  • Whether it should be taken with food
  • Whether tablets can be split, crushed, or chewed
  • Maximum daily amounts
  • Instructions for children, older adults, or people with kidney or liver problems

Many medicines also contain special dosing modifications when they are taken alongside other medicines or certain foods. Regulatory guidance specifically highlights dosage adjustments for drug interactions as safety-critical information. [U.S. Food and Drug Administration]fda.govFood and Drug AdministrationDosage and Administration Section of Labeling for Human…January 12, 2023 — 17 Oct 2022 — FDA recommends in…Published: January 12, 2023

Do not assume all missed-dose advice is the same

Many people skim past the missed-dose section because they think the answer is obvious. In reality, instructions vary considerably between medicines.

A common pattern is:

  • Take the missed dose when remembered. [understoodcare.com]understoodcare.comTiming and DosageGeneral advice for many medicines is to take a missed dose when you remember unless it is close to the next planned time…
  • Skip it if the next dose is due soon.
  • Never double the next dose.

However, this is not universal. Some medicines require different action because timing affects safety or effectiveness. Research has found that missed-dose instructions are often insufficiently understood and can vary substantially between products. U.S. Food and Drug Administration+2PMC [fda.gov]fda.govFood and Drug AdministrationUseful Written Consumer Medication Information (CMI)August 18, 2014 — If it is almost time for your next dose…Published: August 18, 2014

For speed-reading purposes, the missed-dose section should always be read carefully the first time you receive a medicine.

Interaction warnings deserve slow reading

Drug interactions are among the easiest details to overlook and among the most important.

Interactions may involve:

  • Prescription medicines
  • Over-the-counter medicines
  • Herbal remedies
  • Supplements
  • Alcohol
  • Specific foods or drinks

The US Food and Drug Administration notes that interactions can reduce effectiveness, increase side effects, or create harmful reactions. [U.S. Food and Drug Administration]fda.govdrug interactions what you should knowFood and Drug AdministrationDrug Interactions: What You Should Know25 Sept 2013 — Drug interactions may make your drug less effective, ca…

When scanning a leaflet, interaction sections should trigger an automatic slowdown because they often contain information that cannot be inferred from the medicine’s name or purpose.

Medicine leaflets illustration 2

Warnings that change what you should do next

“Do not take” statements are decision points

The most important warning section is often the list of situations in which the medicine should not be used at all.

These warnings may involve:

  • Allergies to ingredients
  • Existing medical conditions
  • Previous reactions to similar medicines
  • Pregnancy or breastfeeding
  • Age restrictions

Unlike general precautions, these statements can indicate that a medicine is unsuitable for a particular person. Missing one sentence in this section can have far greater consequences than missing several paragraphs elsewhere.

Medicine leaflets illustration 3

Learn to spot urgent side-effect warnings

Many side effects listed in leaflets are minor and temporary. Others require immediate action.

Rather than reading every side effect with equal attention, focus on identifying:

  • Symptoms that require urgent medical help
  • Signs of allergic reactions
  • Breathing difficulties
  • Severe skin reactions
  • Serious bleeding
  • Neurological symptoms such as seizures or loss of consciousness

Leaflets commonly separate these from less serious effects, often using phrases such as “stop taking the medicine and seek medical help immediately”. Those phrases should never be skimmed. [U.S. Food and Drug Administration]fda.govFood and Drug AdministrationUseful Written Consumer Medication Information (CMI)August 18, 2014 — If it is almost time for your next dose…Published: August 18, 2014

Watch for newly updated safety information

Medicine safety information changes as new evidence emerges. Regulators regularly update warnings, precautions, and patient information when risks become better understood. [MHRA Products+2GOV.UK]products.mhra.gov.ukMHRA Products Patient Information LeafletThis may mean that there are differences between the information in the…Read more…

This means that a leaflet received today may not be identical to one included with the same medicine several years ago. Readers who are continuing a long-term medicine should not assume that previously read instructions remain unchanged.

A fast but safe reading method

For medicine leaflets, effective speed comes from prioritisation rather than acceleration.

A practical sequence is:

  1. Read the medicine name and confirm it matches the product received.
  2. Scan the contents and section headings.
  3. Read “Do not take” and warning sections carefully.
  4. Read dosage and administration instructions slowly.
  5. Read interaction warnings carefully.
  6. Read missed-dose and overdose instructions.
  7. Identify side effects that require urgent action.
  8. Skim the remaining reference information as needed.

This approach preserves speed while protecting against the most costly reading error: overlooking information that changes how the medicine should be taken.

Why slowing down here actually saves time

People often think reading more slowly is inefficient. With medicine leaflets, the opposite is usually true.

A few extra minutes spent checking dosage, interactions, and warning sections can prevent medication errors, unnecessary side effects, treatment failure, or urgent medical consultations. European regulatory guidance identifies medication errors as a significant public-health problem and emphasises the importance of measures that reduce them. [European Medicines Agency (EMA)]ema.europa.euNovember 23, 2015 — 18 Nov 2015 — Medication errors present a major public health burden and there is a need to optimise risk minimisa…Published: November 23, 2015

For most documents, faster reading is a productivity choice. For medicine leaflets, selective slowing is a safety skill. The reader who skims the overview but carefully studies dosage, interactions, and warning sections is usually reading at the most efficient speed for the task.

Amazon book picks

Further Reading

Books and field guides related to The leaflet sections you should not skim. Use these as the next step if you want deeper reading beyond the article.

BookCover for Thanks for the Feedback

Thanks for the Feedback

By Douglas Stone, Sheila Heen

First published 2014. Subjects: BUSINESS & ECONOMICS / Skills, Interpersonal communication, BUSINESS & ECONOMICS / Decision-Making & Prob...

See on Amazon
Browse more on Amazon: How to Read a Book Mayo Clinic family health book Thanks for the Feedback

As an Amazon Associate I earn from qualifying purchases.

eBay marketplace picks

Marketplace Samples

Example marketplace items related to this page. Use the search link to explore similar finds on eBay.

Using USA
Browse more on eBay.co.uk

Example items shown for inspiration; availability and pricing can change. Branchoria may earn a commission if you purchase through outbound eBay links.

Endnotes

  1. Source: GOV.UK
    Title: medicines packaging labelling and patient information leaflets
    Link: https://www.gov.uk/guidance/medicines-packaging-labelling-and-patient-information-leaflets
    Source snippet

    packaging, labelling and patient information leaflets18 Dec 2014 — The MHRA approves all packaging and labelling information for medicine...

  2. Source: GOV.UK
    Title: best [practice]({{ ‘practice/’ | relative_url }}) guidance on patient information leaflets
    Link: https://www.gov.uk/government/publications/best-practice-guidance-on-patient-information-leaflets
    Source snippet

    29 Dec 2014 — This guidance sets out the legal framework for patient information leaflets as described in EU and national legislation and...

  3. Source: GOV.UK
    Link: https://www.gov.uk/guidance/find-product-information-about-medicines
    Source snippet

    product information about medicinesEvery medicine pack includes a patient information leaflet (PIL), which provides information on using...

  4. Source: assets.publishing.service.gov.uk
    Link: https://assets.publishing.service.gov.uk/media/5fe086c18fa8f5149718d66a/Best_practice_guidance_on_patient_information_leaflets.pdf
    Source snippet

    practice guidance on patient information leaflets (PILs)Information necessary before taking the medicine: Situations where the medicine s...

  5. Source: fda.gov
    Link: https://www.fda.gov/media/72142/download
    Source snippet

    Food and Drug AdministrationDosage and Administration Section of Labeling for Human...January 12, 2023 — 17 Oct 2022 — FDA recommends in...

    Published: January 12, 2023

  6. Source: fda.gov
    Title: drug interactions what you should know
    Link: https://www.fda.gov/drugs/resources-drugs/drug-interactions-what-you-should-know
    Source snippet

    Food and Drug AdministrationDrug Interactions: What You Should Know25 Sept 2013 — Drug interactions may make your drug less effective, ca...

  7. Source: fda.gov
    Link: https://www.fda.gov/media/72574/download
    Source snippet

    Food and Drug AdministrationUseful Written Consumer Medication Information (CMI)August 18, 2014 — If it is almost time for your next dose...

    Published: August 18, 2014

  8. Source: pmc.ncbi.nlm.nih.gov
    Title: PMCWhat should patients do if they miss a dose?
    Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7803707/
    Source snippet

    A systematic...by A Albassam · 2020 · Cited by 30 — Advice on missed doses is generally inadequate. Pharmaceutical companies and regulat...

  9. Source: yellowcard.mhra.gov.uk
    Link: https://yellowcard.mhra.gov.uk/
    Source snippet

    Yellow CardYellow Card | Making medicines and medical devices saferMHRA Homepage for reporting of suspected side effects or adverse drug...

  10. Source: products.mhra.gov.uk
    Title: MHRA Products Patient Information Leaflet
    Link: https://products.mhra.gov.uk/search/?page=1&search=valproate
    Source snippet

    This may mean that there are differences between the information in the...Read more...

  11. Source: GOV.UK
    Link: https://www.gov.uk/government/publications/safety-communications-concerning-medicines-medical-devices-and-other-healthcare-products/safety-communications-concerning-medicines-medical-devices-and-other-healthcare-products
    Source snippet

    communications concerning medicines, medical...25 Mar 2025 — The MHRA continually monitors the safety of products, balancing their benef...

  12. Source: GOV.UK
    Link: https://www.gov.uk/drug-safety-update
    Source snippet

    Safety UpdateAlerts, recalls and safety information: A safety review has been conducted by the MHRA following a Yellow Card report concer...

  13. Source: legislation.gov.uk
    Link: https://www.legislation.gov.uk/ukpga/2021/3/notes/division/8/index.htm
    Source snippet

    It is essential for certain medicines...Read more...

  14. Source: GOV.UK
    Title: submitting changes to labelling and patient information leaflets
    Link: https://www.gov.uk/government/publications/submitting-changes-to-labelling-and-patient-information-leaflets/submitting-changes-to-labelling-and-patient-information-leaflets
    Source snippet

    changes to labelling and patient information...22 Dec 2023 — This guidance document applies to changes in relation to the packaging comp...

  15. Source: products.mhra.gov.uk
    Link: https://products.mhra.gov.uk/
    Source snippet

    HomeEvery medicine pack includes a patient information leaflet (PIL), which provides information on using the medicine safely...

  16. Source: medregs.blog.gov.uk
    Link: https://medregs.blog.gov.uk/2018/06/07/submitting-a-variation-that-impacts-the-smpc-label-and-patient-information-leaflet-pil/
    Source snippet

    a variation that impacts the SmPC, label and...7 Jun 2018 — In addition, clean versions of the relevant SmPC fragments that have been ch...

  17. Source: healthdirect.gov.au
    Link: https://www.healthdirect.gov.au/how-to-read-cmis
    Source snippet

    over medicine; information on possible interactions with other...Read more...

  18. Source: ema.europa.eu
    Link: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guide-risk-minimisation-and-prevention-medication-errors_en.pdf
    Source snippet

    November 23, 2015 — 18 Nov 2015 — Medication errors present a major public health burden and there is a need to optimise risk minimisa...

    Published: November 23, 2015

  19. Source: fda.gov
    Title: pharmacists help you use medicines safely
    Link: https://www.fda.gov/consumers/consumer-updates/fda-pharmacists-help-you-use-medicines-safely
    Source snippet

    31 Aug 2023 — Pharmacists can help people take their medicine properly and continue to take it for as long as recommended.Read more...

Additional References

  1. Source: mtw.nhs.uk
    Link: https://www.mtw.nhs.uk/wp-content/uploads/2019/09/Information-about-your-medicine-STANDARD-PRINT-LEAFLETCORE.pdf
    Source snippet

    Information about your medicinesThis leaflet contains some possible sources of further advice and some general information about medicine...

  2. Source: cpe.org.uk
    Link: https://cpe.org.uk/quality-and-regulations/clinical-governance/patient-safety-incident-reporting/patient-safety-information/
    Source snippet

    Patient safety informationThe Medicines and Healthcare products Regulatory Agency (MHRA) have made changes to the way they issue drug saf...

  3. Source: understoodcare.com
    Link: https://www.understoodcare.com/uc-articles/timing-and-dosage
    Source snippet

    Timing and DosageGeneral advice for many medicines is to take a missed dose when you remember unless it is close to the next planned time...

  4. Source: wmic.wales.nhs.uk
    Link: https://www.wmic.wales.nhs.uk/wp-content/uploads/2022/10/UKMi-Enquiry-Answering-Guidelines-2022-update.pdf
    Source snippet

    range of patient information leaflets about medicines for children to view or...

  5. Source: nhs.uk
    Link: https://www.nhs.uk/tests-and-treatments/medicines-information/
    Source snippet

    informationThis page explains the different types of medicine, the difference between branded drugs and generics, and how the medicines b...

  6. Source: pslhub.org
    Link: https://www.pslhub.org/learn/organisations-linked-to-patient-safety-uk-and-beyond/regulators-and-their-regulations/system-and-product-regulators/mhra/mhra-medicines-packaging-labelling-and-patient-information-leaflets-20-april-2016-version-2-r444/
    Source snippet

    MHRA: Medicines: packaging, labelling and patient...20 Apr 2016 — Guidance from the Medicines and Healthcare products Regulatory Agency...

    Published: april 2016

  7. Source: carelearning.org.uk
    Link: https://carelearning.org.uk/qualifications/level-3-extended-hsc/hsc-dmo6-medication/6-1-explain-the-contents-of-patient-information-leaflets-supplied-with-all-medicines/
    Source snippet

    Explain the contents of patient information leaflets...13 Apr 2025 — These leaflets are often written in straightforward language to hel...

  8. Source: gloshospitals.nhs.uk
    Link: https://www.gloshospitals.nhs.uk/documents/23189/Unlicensed_medicines_information_GHPI0452_02_25.pdf
    Source snippet

    Why are medicines 'licensed'? The makers of medicines must ask the Government for a. Marketing...Read more...

  9. Source: brettonparkhealthcare.co.uk
    Title: MHR A Patient Information Leaflets MHRA Patient Information Leaflets
    Link: https://www.brettonparkhealthcare.co.uk/health-information/mhra-patient-information-leaflets/
    Source snippet

    Rivaroxaban Patient Letter – August 2019 · Carbimazole Patient Letter · Hydrochlorothiazide Patient Letter · Modafinil...Read more...

    Published: August 2019

  10. Source: datapharm.com
    Title: challenges paper leaflet digital patient information leaflets
    Link: https://www.datapharm.com/resource-hub/challenges-paper-leaflet-digital-patient-information-leaflets/
    Source snippet

    The challenges with Patient Information Leaflets17 Mar 2023 — Under MHRA regulations in the UK, the PIL is a legally required document fo...

Topic Tree

Follow this branch

Parent topic

Purpose When Should You Slow Down or Skim?

Related pages 4

More on this topic 3